awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5E
Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5E
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
P2860
Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-4B6FB214-326F-4B45-8FE9-416ABBDECA5E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11d09fc2cfcc1b5f5f869354b580656831b4c52f
P2860
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.